Conor Killmurray

From a 105-year-old cancer survivor recovering from COVID-19 to a 7-year-old finishing his last chemotherapy treatment for lymphoma and also beating COVID-19, here’s what’s making the headlines in the cancer landscape this week.

From a renowned actor passing away after a rare neuroendocrine cancer diagnosis and years of treatment to LUNGevity announcing a new fund for patients with lung cancer in need of financial assistance during the COVID-19 pandemic, here’s what’s happening in the cancer space this week.

The Food and Drug Administration has approved the use of Zejula as a frontline maintenance treatment for adult patients with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer who responded to chemotherapy.

With the growing and evolving field of T-cell therapies, patients with metastatic melanoma have new hopes for effective treatment, but the treatment faces future clinical challenges.

The Food and Drug Administration, under its global Project Orbis, approved the combination of Imbruvica and Rituxan for patients with CLL and SLL.

From a woman with stage 4 colon cancer deciding to stream her wedding on Zoom to a patient with breast cancer sewing masks for at-risk groups across the United States, here’s the cancer news and updates happening amid the COVID-19 pandemic.

Data from the phase 1b/2 trial of Padcev in combination with Keytruda displayed promise for patients with metastatic urothelial carcinoma, but further research is needed.

From legendary singer-songwriter John Prine passing away due to coronavirus complications to one patient’s doctor seeing her through her scan when her family couldn’t be there due to COVID-19 restrictions, here’s what is making the headlines in the cancer space this week.

The Food and Drug Administration approved the dual immunotherapy of Opdivo and Yervoy for the treatment of patients with advanced hepatocellular carcinoma. Here’s what you need to know.

From an investigational cancer therapy being studied as a treatment for COVID-19 to the NBA and NHL helping to raise over $500,000 for prostate cancer research, here’s what’s making headlines in the cancer space this week.

As the novel coronavirus outbreak begins impacting many facets of cancer care in the United States, it’s easy to have possibly missed some of the news surrounding COVID-19 and cancer. Here are four things that our readers may have missed.

From patients having to reschedule treatment appointments due to the novel coronavirus (COVID-19) outbreak, to clinical trials being put on hold, here’s everything you need to know about how the COVID-19 pandemic is impacting patients with cancer.

The COVID-19 pandemic will continue to alter how patients with cancer receive their treatment, and experts within the United States who saw the virus strike early are offering their advice to other hospitals just starting to feel the effects.

From the Food and Drug Administration’s new clinical trial guidelines amid the COVID-19 pandemic to a mother meeting the cancer survivor who received her son’s heart 20 years after his passing, here’s what is making headlines in the cancer space this week.

As CDK 4/6 inhibitors become a bigger part of the treatment of breast cancer, CURE® sat down with clinical nurse specialist Patricia Jakel to discuss the essentials about the drug.

There are a number of treatment options available for patients with urothelial cancer, however, experts want to refine the current treatment paradigm amid new drugs entering the landscape.

The Food and Drug Administration approved the targeted therapy Sarclisa for the treatment of patients with multiple myeloma. Here’s what you need to know.

Being a patient with cancer gives you a unique perspective that can become beneficial when serving as an advocate for others.

The COVID-19 pandemic has reached across the globe and continues to change, rapidly impacting everyone. Here are some of the stories around the world highlighting how the pandemic has impacted the lives of patients with cancer.

African American race was associated with longer survival in non-clear cell metastatic renal cell carcinoma compared with Hispanic and Caucasian patients.

The Food and Drug Administration granted an accelerated approval to the combination of Opdivo and Yervoy for the treatment of patients with advanced hepatocellular carcinoma who were previously treated with Nexavar.

From “Jeopardy!” host Alex Trebek giving an update on his cancer journey after reaching the one-year survival mark to how the new coronavirus outbreak in China has impacted cancer care, here’s what is making headlines in the cancer space this week.

The Food and Drug Administration approved the combination of Nerlynx and Xeloda for adults with advanced or metastatic HER2-positive breast cancer. Here’s what you need to know.

The WISDOM trial seeks to determine if a personalized approach to screening for breast cancer is better than an annual mammogram.

From New Jersey Governor Phil Murphy announcing he will undergo surgery to remove a potentially cancerous tumor on his kidney to an NHL team granting a 15-year-old fan with cancer the ultimate wish, here’s what is making headlines in the cancer space this week.

Patients with a compromised immune system are more susceptible to the coronavirus, including those with cancer. Here are four key things patients with cancer should know about the novel coronavirus.

The Food and Drug Administration has granted approval to the combination of Nerlynx and Xeloda for the treatment of patients with advanced or metastatic HER2-positive breast cancer.

From the first child born to a patient with cancer from an egg matured in a lab to women with breast cancer taking to the runway for New York Fashion Week, here’s what is making headlines in the cancer space this week.

The Food and Drug Administration granted a final approval to pemfexy, a branded alternative chemotherapy injection for patients with advanced or metastatic nonsquamous non-small cell lung cancer, potentially offering them a cheaper treatment option in the future.

From thousands of patients with breast cancer told to be re-checked after a surgeon performed botched surgeries to three young brothers receiving the same eye cancer diagnosis, here’s what is making headlines in the cancer space this week.